US 8790869
Renal cell carcinoma biomarkers
granted A61PA61P35/00
Quick answer
US patent 8790869 (Renal cell carcinoma biomarkers) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P35/00